Related Experiment Video

Updated: Jun 28, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor

Andrew L LaFrate1, Jillian R Gunther, Kathryn E Carlson

  • 1Department of Chemistry, University of Illinois at Urbana-Champaign, 600 S. Mathews Avenue, Urbana, IL 61801, USA.

Bioorganic & Medicinal Chemistry
|November 4, 2008
PubMed

Insights

Researchers developed novel guanylhydrazone molecules to overcome tamoxifen resistance in hormone-responsive breast cancer by blocking estrogen receptor (ER) coactivator binding. These compounds offer a new therapeutic strategy against treatment resistance.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Oncology

Background:

  • Hormone-responsive breast cancer often develops resistance to antiestrogen therapies like tamoxifen.
  • Estrogen receptor (ER) activity, driven by coactivator binding, is crucial for tumor growth.
  • Overcoming treatment resistance is a significant challenge in breast cancer management.

Purpose of the Study:

  • To design and synthesize novel guanylhydrazone small molecules targeting ER.
  • To investigate a non-traditional mechanism of ER inhibition by blocking coactivator binding.
  • To evaluate the efficacy of these compounds in overcoming antiestrogen resistance.

Main Methods:

  • Synthesis and characterization of 16 guanylhydrazone compounds.
  • Cell-based transcription assays using ER-responsive reporter genes.
  • Mammalian two-hybrid assays to assess protein-protein interactions.
  • Secondary assays to confirm the mechanism of action.

Main Results:

  • Several guanylhydrazone compounds demonstrated inhibitory activity with IC(50) values in the low micromolar range.
  • Compounds were confirmed to act via direct interference with coactivator binding to ER.
  • The mechanism was distinct from conventional ER antagonists acting at the ligand-binding site.

Conclusions:

  • Novel guanylhydrazone molecules effectively inhibit ER activity through a non-traditional mechanism.
  • These compounds show potential as a new therapeutic approach for hormone-responsive breast cancer resistant to existing treatments.
  • Targeting coactivator binding represents a promising strategy to overcome endocrine resistance.

More Related Videos

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay06:07

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

Published on: June 7, 2020

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...